Harrow Health, Inc. (HROW) Earnings History
Annual and quarterly earnings data from 2006 to 2025
Loading earnings history...
HROW EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
HROW Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 75.1% | 11.2% | -1.9% |
| 2024 | 75.3% | 4.4% | -8.8% |
| 2023 | 69.6% | 0.3% | -18.7% |
| 2022 | 71.3% | 2.2% | -15.9% |
| 2021 | 74.9% | 2.2% | -24.8% |
Download Data
Export HROW earnings history in CSV or JSON format
Free sign-in required to download data
Harrow Health, Inc. (HROW) Earnings Overview
As of May 8, 2026, Harrow Health, Inc. (HROW) reported trailing twelve-month net income of -$5M, reflecting +71.4% year-over-year growth. The company earned $-0.14 per diluted share over the past four quarters, with a net profit margin of -1.9%.
Looking at the long-term picture, HROW's historical earnings data spans multiple years. The company achieved its highest annual net income of $15M in fiscal 2018.
Harrow Health, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PAHC ($92M net income, 3.7% margin), IMVT (-$464M net income), NUVL (-$450M net income), HROW has room to improve margins relative to the peer group. Compare HROW vs PAHC →
HROW Earnings vs Peers
Earnings metrics vs comparable public companies
HROW Historical Earnings Data (2006–2025)
20 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$5M | +70.6% | $31M | $-0.14 | -1.9% | 11.2% |
| 2024 | -$17M | +28.4% | $9M | $-0.49 | -8.8% | 4.4% |
| 2023 | -$24M | -73.3% | $431,000 | $-0.75 | -18.7% | 0.3% |
| 2022 | -$14M | +21.8% | $2M | $-0.51 | -15.9% | 2.2% |
| 2021 | -$18M | -436.4% | $2M | $-0.69 | -24.8% | 2.2% |
| 2020 | -$3M | -2098.2% | $385,000 | $-0.13 | -6.9% | 0.8% |
| 2019 | $168,000 | -98.9% | -$5M | $0.01 | 0.3% | -9.4% |
| 2018 | $15M | +222.0% | -$5M | $0.61 | 35.3% | -12.6% |
| 2017 | -$12M | +37.2% | -$12M | $-0.60 | -44.8% | -45.4% |
| 2016 | -$19M | -20.1% | -$16M | $-1.50 | -95.7% | -79.6% |
See HROW's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HROW Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HROW vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonHROW — Frequently Asked Questions
Quick answers to the most common questions about buying HROW stock.
Is HROW growing earnings?
HROW EPS is $-0.14, with earnings growth accelerating to +71.4%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-5M.
What are HROW's profit margins?
Harrow Health, Inc. net margin is -1.9%, with operating margin at +11.2%. Below-average margins reflect competitive or cost pressures.
How consistent are HROW's earnings?
HROW earnings data spans 2006-2025. The accelerating earnings trend is +71.4% YoY. Historical data enables comparison across business cycles.